Overview
Information for Industry
Information for Research Participants
Information for Investigators/Study Coordinators
Frequently Asked Questions
Clinical Research Administration Staff
19 February 2004
Main Page for Food and Drug Administration http://www.fda.gov
Center for Drug Evaluation and Research http://www.fda.gov/cder/
Drug Applications http://www.fda.gov/cder/regulatory/applications/default.htm
Investigational New Drug (IND) Application http://www.fda.gov/cder/regulatory/applications/ind_page_1.htm
Introduction http://www.fda.gov/cder/regulatory/applications/ind_page_1.htm#Introduction
Three types of applications
Interactive Chart http://www.fda.gov/cder/handbook/ind.htm
Pre-IND Consultation Program http://www.fda.gov/cder/ode4/preind/default.htm
Content and Format for INDs for Phase I Studies http://www.fda.gov/cder/guidance/phase1.pdf
Exemptions of Marketed Drugs for Treatment of Cancer http://www.fda.gov/cder/guidance/6036fnl.pdf
Information for Clinical Investigators http://www.fda.gov/cder/about/smallbiz/clinical_investigator.htm
General Information http://www.fda.gov/cder/about/smallbiz/general_info.htm
IRBs and Protection of Human Subjects http://www.fda.gov/cder/about/smallbiz/humans.htm
Clinical Investigator Inspection http://www.fda.gov/cder/regulatory/investigators/default.htm
Regulatory and Compliance Information http://www.fda.gov/cder/about/smallbiz/regs_and_compliance.htm
Clinical Investigator Forms
Disclosure of Financial Interests http://forms.psc.gov/forms/FDA/FDA-3455.pdf
FDA Forms http://forms.psc.gov/forms/FDA/fda.html
Form 1571 http://forms.psc.gov/forms/FDA/1571es.pdf
Form 1572 http://forms.psc.gov/forms/FDA/FDA-1572.pdf
Instructions for 1571 and 1572 http://www.fda.gov/cder/forms/1571-1572-help.html
FAQs on Drug Development http://www.fda.gov/cder/about/smallbiz/faq.htm
When can a trial start? When is an IND number assigned? Exemption
Exemption Request to FDA Sample letter
Exemption Letter from FDA Sample letter
Submission of an IND Application Sample 1571 Sample Application